Lung Cancer ORIENT-11 Asian Results: Applicability in West according to ICH- E5 Framework Mar 29, 2023
Lung Cancer ATTRACTION-2 Study: Nivolumab±ipilimumab vs. Placebo for HPD and Natural Disease Progression Mar 29, 2023
Lung Cancer GEMSTONE-301 PHASE III: Sugemalimab vs. Placebo in Chemoradiotherapy Patients Mar 28, 2023
Breast Cancer,HER2+ Phase 3 PRECIOUS Study: Pertuzumab Retreatment Benefits for HER2+ Cancer Patients Mar 28, 2023
Breast Cancer,HER2- Comparison of PAL + FUL vs. CAPE in the GEICAM/2013-02 (PEARL) Phase 3 Trial Mar 28, 2023
